Veru (VERU) Goodwill (2016 - 2026)

Veru (VERU) posted quarterly Goodwill of $6.9 million for Q3 2025, little changed quarter-over-quarter from $6.9 million in Q2 2025.

Veru (VERU) Goodwill (2016 - 2026) Analysis & Trends

Veru (VERU) has reported Goodwill for 7 consecutive years, with $6.9 million the latest figure, recorded in Q3 2025.

In Q3 2025, Goodwill changed N/A year-over-year to $6.9 million; the TTM figure through Sep 2025 stood at $6.9 million (changed N/A YoY), while the FY2025 annual figure was $6.9 million, changed N/A from the prior year.
Goodwill held at $6.9 million in Q3 2025 per VERU's latest filing, from $6.9 million in the prior quarter.
Across five years, Goodwill topped out at $6.9 million in Q2 2025 and bottomed at $6.9 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.41 Bn	130.56 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.12 Bn	78.12 Bn	3.93 Bn
3	Argenx Se	64.41 Bn	59.23 Bn	1.37 Bn
4	Moderna	57.56 Bn	52.43 Bn	52.00 Mn
5	BeOne Medicines	42.06 Bn	36.96 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.95 Bn	27.65 Bn	992.69 Mn
7	BioNTech SE	27.48 Bn	9.09 Bn	668.28 Mn
8	Insmed	27.31 Bn	26.15 Bn	358.27 Mn
9	Royalty Pharma	27.04 Bn	26.20 Bn	-
10	Veru	60.39 Mn	34.60 Mn	-

Download Data